Kathryn Gudsnuk

Kathryn Gudsnuk

Auto-generated profile, based on publicly available information

Kathryn Gudsnuk

Allen Institute for Brain Science

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Neuroepigenetics
Verified
Journal Article
Open access
RMRachel L. Miller
Rachel L. Miller
ZYZhonghai Yan
Zhonghai Yan
CMChristina Maher
Christina Maher
HZHanjie Zhang
Hanjie Zhang
KGKathryn Gudsnuk
Kathryn Gudsnuk
FCFrances A. Champagne
Frances A. Champagne
Prenatal exposure to polycyclic aromatic hydrocarbons (PAH) has been associated with sustained effects on the brain and behavior in offspring. However, the mechanisms have yet to be determined. We hypothesized that prenatal exposure to ambient PAH in mice would be associated with impaired neurocognition, increased anxiety, altered cortical expression of Bdnf and Grin2b, and greater DNA methylation of Bdnf. Our results indicated that during open-field testing, prenatal PAH exposed offspring spent more time immobile and less time exploring. Females produced more fecal boli. Offspring prenatally exposed to PAH displayed modest reductions in overall exploration of objects. Further, prenatal PAH exposure was associated with lower cortical expression of Grin2b and Bdnf in males, and greater Bdnf IV promoter methylation. Epigenetic differences within the Bdnf IV promoter correlated with Bdnf gene expression, but not with the observed behavioral outcomes, suggesting that additional targets may account for these PAH-associated effects.

9 July 2021 in Genome Research
Verified
Journal Article
Open access
PDF file
MCMeredith M. Course
Meredith M. Course
ASArvis Sulovari
Arvis Sulovari
KGKathryn Gudsnuk
Kathryn Gudsnuk
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Paul ValdmanisPaul Valdmanis
Paul Valdmanis
There are more than 55,000 variable number tandem repeats (VNTRs) in the human genome, notable for both their striking polymorphism and mutability. Despite their role in human evolution and genomic variation, they have yet to be studied collectively and in detail, partially owing to their large size, variability, and predominant location in noncoding regions. Here, we examine 467 VNTRs that are human-specific expansions, unique to one location in the genome, and not associated with retrotransposons. We leverage publicly available long-read genomes, including from the Human Genome Structural Variant Consortium, to ascertain the exact nucleotide composition of these VNTRs and compare their composition of alleles. We then confirm repeat unit composition in more than 3000 short-read samples from the 1000 Genomes Project. Our analysis reveals that these VNTRs contain highly structured repeat motif organization, modified by frequent deletion and duplication events. Although overall VNTR compositions tend to remain similar between 1000 Genomes Project superpopulations, we describe a notable exception with substantial differences in repeat composition (in PCBP3), as well as several VNTRs that are significantly different in length between superpopulations (in ART1, PROP1, DYNC2I1, and LOC102723906). We also observe that most of these VNTRs are expanded in archaic human genomes, yet remain stable in length between single generations. Collectively, our findings indicate that repeat motif variability, repeat composition, and repeat length are all informative modalities to consider when characterizing VNTRs and their contribution to genomic variation.

31 July 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
EKEmily Kussick
Emily Kussick
NJNelson Johansen
Nelson Johansen
NTNaz Taskin
Naz Taskin
ACAnanya Chowdhury
Ananya Chowdhury
MQMeagan A. Quinlan
Meagan A. Quinlan
TDTanya L. Daigle
Tanya L. Daigle
Summary: Experimental access to cell types within the mammalian spinal cord is severely limited by the availability of genetic tools. To enable access to lower motor neurons (LMNs) and LMN subtypes, we generated single cell multiome datasets from mouse and macaque spinal cords and discovered putative enhancers for each neuronal population. We cloned these enhancers into adeno-associated viral vectors (AAVs) driving a reporter fluorophore and functionally screened them in mouse. We extensively characterized the most promising candidate enhancers in rat and macaque and developed an optimized pan LMN enhancer virus. Additionally, we generated derivative viruses expressing iCre297T recombinase or ChR2-EYFP for labeling and functional studies, and we created a single vector with combined enhancer elements to achieve simultaneous labeling of layer 5 extratelencephalic projecting (ET) neurons and LMNs. This unprecedented LMN toolkit will enable future investigations of cell type function across species and potential therapeutic interventions for human neurodegenerative diseases.

4 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MFMichal G. Fortuna
Michal G. Fortuna
LNLyle Nyberg
Lyle Nyberg
NTNaz Taskin
Naz Taskin
NWNatalie Weed
Natalie Weed
AHAvery Hunker
Avery Hunker
JTJonathan T. Ting
Jonathan T. Ting
Adeno-associated virus (AAV) vectors are pivotal in gene therapy for neurological disorders due to their ability to enable long-term gene expression in the central nervous system (CNS). However, transducing larger brains, such as those of non-human primates (NHPs), remains challenging, necessitating alternative delivery routes and optimized capsids. This study directly compares the transduction efficiency and biodistribution of the benchmark AAV9 and its engineered derivative, AAV-PHP.eB, following intracerebroventricular (ICV) administration in juvenile Macaca nemestrina . Employing a neuron-specific promoter and nuclear-localized reporter, we systematically quantified transduction across cortical, subcortical, and spinal regions. AAV-PHP.eB demonstrated significantly higher transduction rates in cortical and spinal regions compared to AAV9, despite similar expression patterns. Both vectors exhibited limited subcortical penetration and significant peripheral leakage, highlighting key challenges in CNS targeting. This is the first study to quantitatively compare AAV-PHP.eB and AAV9 in NHPs, providing valuable insights into the advantages and limitations of engineered AAV capsids for CNS gene therapy. These findings lay a critical foundation for optimizing vector designs and delivery strategies to improve outcomes in clinical applications for neurodegenerative and neurodevelopmental disorders.

16 June 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
IJIan P Johnson
Ian P Johnson
TPTia M Peterson
Tia M Peterson
KGKathryn Gudsnuk
Kathryn Gudsnuk
CKC Dirk Keene
C Dirk Keene
TBThomas D Bird
Thomas D Bird
MCMeredith M Course
Meredith M Course
Circular RNAs (circRNAs) are emerging as a promising object of study in Alzheimer's disease (AD) pathogenesis. Expression differences in circRNAs have been correlated with disease; however, the presence of pathogenic variants has not been observed until now. Here, we examine circRNAs derived from two AD-related genes, presenilin 1 ( PSEN1 ) and presenilin 2 ( PSEN2 ), in the prefrontal cortex from individuals with familial AD, identifying four variants in circRNAs derived from PSEN1 (I143T, S212Y, M146L) and PSEN2 (N141I). The discovery of pathogenic variants in PSEN1 and PSEN2 circRNAs marks a first step in determining whether they play a role in AD etiology.

11 November 2026 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
EKEli Jonah Kaufman
Eli Jonah Kaufman
SSSamuel N. Smukowski
Samuel N. Smukowski
KGKathryn Gudsnuk
Kathryn Gudsnuk
MCMeredith M. Course
Meredith M. Course
Paul ValdmanisPaul Valdmanis
Paul Valdmanis
Background and ObjectivesATP-binding cassette subfamily A member 7 (ABCA7) variants are a well-established genetic risk factor for Alzheimer disease (AD). This risk includes increased length of a v...